Fabrizio Montecucco Selected Research

Fabrizio Montecucco Research Topics

Disease

56	Atherosclerosis 02/2022 - 01/2008
44	Inflammation (Inflammations) 12/2021 - 06/2006
41	Atherosclerotic Plaque (Atheroma) 02/2022 - 12/2006
27	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 01/2009
23	Myocardial Infarction 07/2021 - 02/2011
20	Ischemic Stroke 07/2021 - 07/2010
17	Infarction (Infarctions) 01/2020 - 05/2009
15	Stroke (Strokes) 12/2021 - 01/2012
14	Thrombosis (Thrombus) 01/2022 - 01/2012
13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2008
12	Obesity 04/2022 - 01/2008
12	Insulin Resistance 02/2021 - 01/2008
11	Acute Coronary Syndrome 01/2021 - 04/2013
11	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 02/2011
10	Neoplasms (Cancer) 08/2021 - 01/2008
9	Carotid Artery Diseases 02/2022 - 04/2013
9	Hypertension (High Blood Pressure) 01/2022 - 01/2008
9	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2006
7	Ischemia 01/2020 - 05/2009
7	Necrosis 10/2018 - 05/2011
6	Rupture 02/2022 - 01/2007
6	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2008
6	Reperfusion Injury 01/2019 - 11/2013
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 01/2017
6	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2007
5	Coronary Disease (Coronary Heart Disease) 01/2022 - 11/2013
5	Hemorrhage 01/2022 - 01/2015
5	Metabolic Diseases (Metabolic Disease) 02/2021 - 01/2015
5	Non-alcoholic Fatty Liver Disease 01/2021 - 12/2008
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020 - 01/2017
5	Heart Failure 02/2019 - 08/2012
5	Pathologic Constriction (Stenosis) 12/2018 - 08/2012
4	Hypercholesterolemia 01/2022 - 10/2013
4	Chronic Disease (Chronic Diseases) 01/2021 - 01/2009
4	Diabetes Complications 01/2021 - 01/2013
4	Sepsis (Septicemia) 10/2020 - 01/2018
4	Hyperglycemia 05/2018 - 01/2013
4	Myocardial Reperfusion Injury 04/2016 - 08/2009
4	Erectile Dysfunction 02/2015 - 01/2013
3	Pulmonary Embolism 01/2022 - 12/2012
3	Diabetes Mellitus 01/2021 - 05/2018
3	Infections 01/2021 - 05/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 05/2019
3	Septic Shock (Toxic Shock Syndrome) 10/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

26	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
22	LipidsIBA 12/2021 - 01/2008
20	ChemokinesIBA 01/2022 - 01/2008
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 06/2009
17	CytokinesIBA 01/2021 - 01/2007
16	Immunoglobulin G (IgG)IBA 10/2020 - 07/2007
14	Apolipoproteins E (ApoE)IBA 02/2022 - 02/2011
14	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 09/2010
10	AdipokinesIBA 08/2021 - 07/2013
10	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 01/2008
10	EndocannabinoidsIBA 10/2016 - 01/2009
9	AutoantibodiesIBA 10/2020 - 01/2015
9	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 07/2010
8	CholesterolIBA 02/2022 - 08/2015
8	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
8	LeptinIBA 01/2021 - 06/2006
8	CollagenIBA 10/2020 - 01/2013
8	C-Reactive ProteinIBA 11/2019 - 12/2012
7	RNA (Ribonucleic Acid)IBA 02/2022 - 07/2015
7	OsteopontinIBA 01/2022 - 06/2015
7	Matrix Metalloproteinases (MMPs)IBA 11/2021 - 03/2012
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2009
7	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2007
6	Insulin (Novolin)FDA Link 01/2021 - 12/2006
6	Oxidants (Oxidizing Agents)IBA 01/2019 - 12/2008
6	Nicotinamide PhosphoribosyltransferaseIBA 12/2016 - 01/2013
6	CXC ChemokinesIBA 10/2014 - 07/2010
5	AdiponectinIBA 04/2022 - 01/2017
5	ApolipoproteinsIBA 02/2022 - 01/2012
5	InflammasomesIBA 12/2021 - 01/2019
5	LDL CholesterolIBA 12/2020 - 01/2018
5	ResistinIBA 10/2020 - 12/2012
5	AntibodiesIBA 01/2020 - 02/2011
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2013
5	CannabinoidsIBA 01/2018 - 01/2009
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2015 - 01/2009
5	EnzymesIBA 12/2014 - 12/2009
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2014 - 05/2009
4	LigandsIBA 01/2022 - 01/2007
4	Protein Isoforms (Isoforms)IBA 02/2020 - 01/2007
4	Lipoproteins (Lipoprotein)IBA 01/2020 - 03/2016
4	Troponin IIBA 03/2016 - 05/2009
4	AngiotensinsIBA 11/2015 - 01/2009
4	angiotensin I (1-7)IBA 02/2015 - 12/2012
4	Hormones (Hormone)IBA 01/2013 - 01/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2022 - 06/2016
3	Antineoplastic Agents (Antineoplastics)IBA 08/2021 - 12/2014
3	Colchicine FDA LinkGeneric 02/2021 - 01/2019
3	Therapeutic UsesIBA 01/2021 - 12/2011
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 04/2013
3	oxidized low density lipoproteinIBA 01/2020 - 09/2010

Therapy/Procedure

25	Therapeutics 01/2022 - 08/2009
4	Bariatric Surgery 02/2021 - 10/2017
4	Glycemic Control 01/2021 - 09/2015
4	Endarterectomy (Thromboendarterectomy) 01/2021 - 10/2016
3	Carotid Endarterectomy 10/2020 - 01/2018